A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2004
10/07/2004	US20040198718 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
10/07/2004	US20040198709 Compositions and methods for enhancing corticosteroid delivery
10/07/2004	US20040198696 Agent and food for inhibiting IgE antibody
10/07/2004	US20040198694 Formulation to treat or prevent parasitic infection
10/07/2004	US20040198677 macrolide and steroidal or non-steroidal substructures connected by an alkyl linker; esterification or amidation to couple; antiarthritic, antiasthmatic agents, nasal, gastrointestinal, dermatological and opthalmic disorders; veterinary or human therapy
10/07/2004	US20040198651 Secreted proteins
10/07/2004	US20040198649 a VR4 peptide, a VR4 polypeptide modulator, a VR4 polynucleotide, or an antisense agent as analgesics or antiarthritic agents for bone and cartilage disorders; rheumatoid and osteoarthritis, osteoperosis; biodrugs
10/07/2004	US20040197876 Recombinant fusion proteins and the trimers thereof
10/07/2004	US20040197871 for diagnosing and treating inflammatory bowel disease using purified polypeptide; genetic engineering
10/07/2004	US20040197847 High throughput screening assays using fatty acid synthetic enzymes
10/07/2004	US20040197786 Method of examining steroid resnponsiveness
10/07/2004	US20040197429 Selective COX-2 inhibition from plant extracts
10/07/2004	US20040197399 N-fatty acid-amino acid conjugates and therapeutic uses
10/07/2004	US20040197345 Prostate derived Ets factor
10/07/2004	US20040197341 Therapeutic process for p. aeruginosa infections using macrolide antibiotics
10/07/2004	US20040197335 Non-myeloablative tolerogenic treatment with tyrphostins
10/07/2004	US20040197329 Remedies or preventives for rheumatoid arthritis
10/07/2004	US20040197327 Administering antagonist of receptor on surface of lymphocytes; therapy for multiple sclerosis; antidiabetic agents
10/07/2004	US20040197307 Mixture of human interferons
10/07/2004	US20040197303 For therapy of inflammation and diseases or conditions associated with autoimmune responses
10/07/2004	CA2561082A1 Anti-inflammatory treatment based on strontium compounds
10/07/2004	CA2520443A1 Methods for treating inflammatory conditions or inhibiting jnk
10/07/2004	CA2520147A1 Compound having affinity with calcified tissue
10/07/2004	CA2519465A1 Elevation of adenosine level by cytokine-induced expression of cd73
10/07/2004	CA2519038A1 Oral delivery system comprising an antibacterial and an anti-inflammatory agent
10/07/2004	CA2505590A1 Bis-aryl sulfonamides
10/06/2004	EP1464646A1 Thieno(2,3-C) Isoquinolines for use as inhibitors of Parp
10/06/2004	EP1464639A1 Succinic acid ester of probucol for the inhibition of the expression of VCAM-1
10/06/2004	EP1464636A1 Novel substance having antitumor/anti-inflammatory activity
10/06/2004	EP1464330A1 Use of a composition containing oligosaccharides in combination with a saponine or a basic aminoacid, for topical administration or for inhalation
10/06/2004	EP1463817A2 Histamine receptor h3 polynucleotides
10/06/2004	EP1463806A2 Novel cyclooxygenase variants and methods of use
10/06/2004	EP1463803A2 Hematopoietic cells from human embryonic stem cells
10/06/2004	EP1463799A2 Methods for the induction of professional and cytokine-producing regulatory cells
10/06/2004	EP1463760A2 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof
10/06/2004	EP1463759A1 Ligand for g-protein coupled receptor gpr43 and uses thereof
10/06/2004	EP1463758A2 Mammal prolactin variants
10/06/2004	EP1463756A2 Secreted proteins
10/06/2004	EP1463755A2 Recombinant polypeptides
10/06/2004	EP1463754A2 Cystine-knot fold protein
10/06/2004	EP1463731A1 Dibenzodiazepine derivates, their preparation and use
10/06/2004	EP1463728A2 Fused cyclic modulators of nuclear hormone receptor function
10/06/2004	EP1463721A1 Compounds for imaging alzheimer's disease
10/06/2004	EP1463719A2 Eponemycin and epoxomicin analogs and uses thereof
10/06/2004	EP1463716A1 Pyrrolidine and piperidine derivates as nk1 antagonists
10/06/2004	EP1463714A2 Vanilloid receptor ligands and their use in treatments
10/06/2004	EP1463707A2 A group of novel anti-cancer compounds with specific structure
10/06/2004	EP1463509A1 Type 4 phosphodiesterase inhibitors and uses thereof
10/06/2004	EP1463507A1 Thienopyrimidine compounds as protein tyrosine kinase inhibitors
10/06/2004	EP1463500A1 Use of cox-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections
10/06/2004	EP1463498A1 Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
10/06/2004	EP1463491A1 Thin film with non-self-aggregating uniform heterogeneity, process for ther production and drug delivery systems made therefrom
10/06/2004	EP1463487A1 Liposomal delivery of vitamin e based compounds
10/06/2004	EP1463412A2 Composition comprising wenguanguo extracts, methods for preparing same and uses therof
10/06/2004	EP1303632B1 Galactomannan oligosaccharides and methods for the production and use thereof
10/06/2004	EP1248787B1 NOVEL SUBTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM
10/06/2004	EP1210325B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha
10/06/2004	EP1202743B1 Pharmaceutical and cosmetic compositions comprising cod serine proteases and their pharmaceutical and cosmetic use
10/06/2004	EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents
10/06/2004	EP1154993B1 Thioamide derivatives
10/06/2004	EP1144403B1 Substituted pyrazoles as p38 kinase inhibitors
10/06/2004	EP1135163B1 Topical compositions comprising ascomycins
10/06/2004	EP1133284B1 A process for the preparation of crystalline particles
10/06/2004	EP1027336B1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
10/06/2004	EP0869810B1 Cyclosporin-containing soft capsule preparations
10/06/2004	EP0868425B1 Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments
10/06/2004	EP0821551B1 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor
10/06/2004	CN1535312A PUFA polyketide synthase systems and uses thereof
10/06/2004	CN1535160A Use of IL-18 inhibitors for treating or preventing CNS injuries
10/06/2004	CN1535156A Use of disintegrain domain of adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent
10/06/2004	CN1535153A Method of implanting heavy method such as nobel metal, E.G. glod, and metal for use in implantation
10/06/2004	CN1535152A Use of bisphosphonates for pain treatment
10/06/2004	CN1535151A Novel anti-infectives
10/06/2004	CN1534285A Head flower knotweed and its extract and product bioactivity measuring method
10/06/2004	CN1534017A N-(2-phenyl-4-amino-batyl)-1-naphthol carboxy amide kind compound used as neuropeptide-1-acceptor antagonistic agent
10/06/2004	CN1533801A Golden hairpin dendrobium extract and its medicinal composition
10/06/2004	CN1533782A Preparation method of dairy cattle mammitis anhinflammation powder
10/06/2004	CN1533764A Slow release injection preparation containing non sterol anti inflammation medicine
10/06/2004	CN1169959C Polypeptide variants with raised heparin-binding capacity
10/06/2004	CN1169830C Conotoxin peptide
10/06/2004	CN1169805C Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products
10/06/2004	CN1169788C N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
10/06/2004	CN1169579C Medicine C60-AEDP using C60 as carrier for target therapy of osteopath and its usage
10/06/2004	CN1169563C Strengthening-bone bills contg. cortex Eucommiae for treating RD
10/06/2004	CN1169562C External use ointment for restoring period of knocks and falls
10/06/2004	CN1169559C Medical Liquor for treating rheuamtic arthritis ischias, etc
10/06/2004	CN1169553C Medicinal wine for curing rheumatism rheumatoid and various diseases caused by wind and cold
10/06/2004	CN1169548C Chinese medicine preparation for curing atrophic arthritis
10/06/2004	CN1169542C Tonic wine for resisting rheumatism and rhematoid diseases
10/06/2004	CN1169532C Liquor for treating rheumatism and arthritis
10/05/2004	US6800654 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
10/05/2004	US6800647 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3]bipyridinyl in pure crystalline form and process for synthesis
10/05/2004	US6800645 Substituted azabicyclic compounds
10/05/2004	US6800644 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds
10/05/2004	US6800643 Mixtures for organic compounds for the treatment of airway diseases
10/05/2004	US6800633 Pyrrolo[2,3d]pyrimidine compositions and their use
10/05/2004	US6800626 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc.
10/05/2004	US6800620 Contacting leukocytes, osteoclasts with an enzyme inhibitors, a 9h-purin-3h-quinazolin-4-one derivatives, treating bone-resorption disorder, antiproliferative agents treating leukemia cells
10/05/2004	US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives
10/05/2004	US6800613 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds

1 ... 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 ... 1272